MedTrace Logo

Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia

NCT06277362 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-03-24

No results posted yet for this study

Summary

The objective of the study is to evaluate early safety and effectiveness of the percutaneous deep foot venous arterialization performed in clinical practice, in an unselected population of patients with "no-option" CLTI.

Conditions

  • Peripheral Arterial Disease
  • Critical Limb-Threatening Ischemia
  • Diabetic Foot

Sponsors & Collaborators

  • EndoCore Lab s.r.l.

    lead OTHER

Principal Investigators

  • Gabriele Morselli, PharmD · EndocoCore Lab s.r.l.

  • Bruno Migliara, MD · Casa di Cura Pederzoli

  • Marco Manzi, MD · Casa di Cura Abano Terme

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06277362 on ClinicalTrials.gov